市場調查報告書

全球分子診斷市場:2025年為止的預測

Global Molecular Diagnostics Market Research Report Forecast to 2025

出版商 Market Research Future 商品編碼 916686
出版日期 內容資訊 英文 130 Pages
訂單完成後即時交付
價格
全球分子診斷市場:2025年為止的預測 Global Molecular Diagnostics Market Research Report Forecast to 2025
出版日期: 2019年10月31日內容資訊: 英文 130 Pages
簡介

本報告提供全球分子診斷市場的相關調查,市場機會,成長及阻礙因素,各產品、技術、用途、終端用戶、地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 摘要整理

第2章 市場介紹

  • 定義
  • 調查範圍
  • 前提條件及限制
    • 前提條件
    • 限制事項
  • 市場結構

第3章 調查方法

  • 調查方法
  • 一次調查
  • 二次調查
  • 市場規模的估計
  • 預測模式

第4章 市場動態

  • 概要
  • 成長要素
    • 感染疾病的增加率
    • 分子診斷技術的進步
    • 多樣類型的癌症盛行率上升
  • 阻礙因素
    • 嚴格的法規政策
  • 市場機會
    • 新興國家的進入
  • 技術趨勢、評估

第5章 市場要素分析

  • 價值鏈分析
    • 研究開發、設計
    • 優良實驗室標準(GLP)
    • 分子診斷試驗
    • 流通、銷售
    • 銷售後的監測
  • 波特的五力分析
    • 供應商談判力
    • 買主談判力
    • 新加入廠商的威脅
    • 替代品的威脅
    • 產業內的競爭
  • 投資機會
  • 價格分析

第6章 市場分析:各產品

  • 概要
  • 試劑、套件
  • 設備
  • 服務、軟體

第7章 市場分析:各技術

  • 概要
  • 聚合酵素鏈鎖反應(PCR)
  • 等溫放大
  • 雜合反應
  • 序列
  • 微陣列
  • 其他

第8章 市場分析:各用途

  • 概要
  • 感染疾病
  • 腫瘤學
  • 遺傳基因檢驗
  • 其他

第9章 市場分析:各終端用戶

  • 概要
  • 醫院、診療所
  • 診斷研究所
  • 其他

第10章 市場分析:各地區

  • 概要
  • 南北美洲
    • 北美
    • 南美
  • 歐洲
    • 西歐
    • 東歐
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 韓國
    • 澳洲
    • 其他
  • 中東、非洲
    • 中東
    • 非洲

第11章 競爭情形

  • 概要
  • 企業佔有率分析
  • 競爭的基準
  • 市場開發數的主要企業
  • 主要開發分析
    • 聯盟/策略性協定
    • 取得
    • 產品的認證
    • 產品的銷售

第12章 企業簡介

  • F. Hoffmann-La Roche Ltd
  • Hologic, Inc.
  • Qiagen
  • Becton, Dickinson, and Company
  • Abbott Laboratories
  • Cepheid
  • Siemens
  • CLONIT srl
  • Thermo Fisher Scientific Inc.
  • Agilent Technologies
  • EKF Diagnostics
  • Novartis
  • Illumina

第13章 附錄

  • 參照資料
  • 相關報告
目錄

Molecular Diagnostics Market Research Report: Information by Product (Reagents & Kits, Instruments and Services & Software), by Technique (Polymerase Chain Reaction (PCR), Isothermal Amplification, Hybridization, Sequencing, Microarray and others), by Application (Infectious Diseases, Oncology, Genetic Tests and others), by End User (Hospitals & Clinics, Diagnostic Laboratories and others) and by Region (Americas, Europe, Asia-Pacific and the Middle East & Africa) - Global Forecast till 2025

Market analysis

Generally, Molecular diagnostic tests have begun a transformation in the diagnosis and checking of infectious diseases over the past several years. Various molecular diagnostic tests such as microbial phenotypic characteristics, chromatographic profiles, bio typing, and vulnerability assessment are most generally used in laboratories for the exposure and diversity of infectious illnesses. But nucleic acid practices and polymerase chain reaction (PCR) are most usually used to carry out testing for communicable diseases. As delineated, molecular analytic is a anthology of skills used to investigate biological markers in genome and proteome. It improves to diagnose and monitor diseases and helps determine which therapy should be administered to the patient. However, the growing frequency of the infectious virus, increasing awareness regarding molecular diagnostic techniques, and development in molecular diagnostics are the primary factors responsible for market growth during the projection period. PCR-based systems are used to detect the etiologic agents of disease directly from clinical samples without the use of culture media. This system is useful in the quick detection of unculturable or fastidious microorganisms. Other significant advances include the determination of viral load and the direct exposure of genes or gene changes accountable for drug resistance. Increased use of automation and user-friendly molecular diagnostic software makes these knowledges more broadly accessible in the marketplace. As a soaring prevalence of infectious disease is detected, the call for molecular diagnostic scanning is also increasing. Overall there has been a notable increase in the number of new and ongoing molecular diagnostic tests as linked to earlier years. Hence, the demand for molecular diagnostics is projected to grow in the future.

Market segmentation

The Global Molecular Diagnostics Market has been segmented into product, technique, application, end user and by region. In June 2019, company QIAGEN and McKesson penetrated a delivery contract for the supply of QIAstat-Dx Syndromic Testing Solution to smaller hospitals and other end users in the US. This augmented the delivery network of QIAGEN and McKesson. Additional company in the report can be provided are Bio-Rad Laboratories Inc., Alere, Inc., Bayer AG, Danaher, Sysmex Corporation. Based on application, the market has been bifurcated into infectious disorders, oncology, genetic tests, and others. In January 2019, Hologic, Inc., accepted the US Food and Drug Administration (FDA) approval for the Aptima Mycoplasma Genitalium Assay, used to detect ordinary sexually communicated diseases (STIs). The Aptima assay offered by Hologic, Inc., has helped to thwart the STIs in the US. By end user, the market has been categorized as hospitals & clinics, diagnostic laboratories, and others. The hospitals & clinics segment settled for a market worth of USD 4.078.09 million in 2018. By product, the market has been segregated into reagents & kits, instruments, and services & software. Based on the technique, the market has been divided into a polymerase chain reaction (PCR), isothermal amplification, hybridization, sequencing, microarray, and others. In May 2019, Clonit launched the Quanty Usutu Kit for the identification and quantification of Usutu virus. With this, the company has finalized its range of Arbovirus molecular scans.

Regional analysis

Geographically, Global Molecular Diagnostics Market is split in regions like North & Latin America, Europe, Asia-Pacific, Middle east and Africa and Rest of the world. the companies operating in the market are mainly focusing on mergers & purchase, which is likely to support market progress. Asia-Pacific is anticipated to be the sharpest-expanding market owing to emerging nations such as China, India, and South Korea emerging as major purposes for the subcontracting of clinical trials, drug production, and pathology assessment. In addition to this, improving healthcare infrastructure has increased the researches being conducted in the region. Additionally, in Asia-Pacific, China settled for a market share of 21.4% in 2018. The molecular diagnostics market in the Middle East & Africa is projected to witness steady growth during the evaluation period due to a lack of understanding of healthcare amenities. In Addition, the global molecular diagnostics market, based on region, has been apportioned into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas is estimated to dominate the global molecular diagnostics market for the duration of the prediction period. This is attributed to the increasing geriatric population and the availability of advanced healthcare amenities in the region. The Europe market for molecular diagnostics is projected to be the second biggest during the projection period. The accessibility of assets for research & development and rising support from the government for the life science sector are anticipated to improve the expansion of the market in this province.

Major players

The proposed spectators in the Global Molecular Diagnostics Market are Medical device manufacturers and distributors, Retailers, distributors, wholesalers, Investors and trade experts, Governments, associations, industrial bodies, etc. The major companies functioning in the Global Molecular Diagnostics Market are concentrating on firming their global ways by entering into untouched markets. The projected onlookers in the Global Molecular Diagnostics Market are companies like Hologic, Inc.; QIAGEN; Becton, Dickinson and Company; Abbott Laboratories; Cepheid; F. Hoffmann-La Roche Ltd Thermo Fisher Scientific; Agilent Technologies and Siemens. The key strategies followed by the players operating in the global molecular diagnostics market were innovation, product development, acquisition, and expansion.

Table of Contents

1 Executive Summary

2 Market Introduction

  • 2.1 Definition
  • 2.2 Scope of the Study
  • 2.3 Assumptions & Limitations
    • 2.3.1 Assumptions
    • 2.3.2 Limitations
  • 2.4 Market Structure

3 Research Methodology

  • 3.1 Research Process
  • 3.2 Primary Research
  • 3.3 Secondary Research
  • 3.4 Market Size Estimation
  • 3.5 Forecast Model

4 Market Dynamics

  • 4.1 Overview
  • 4.2 Drivers
    • 4.2.1 Rising Prevalence of Infectious Diseases
    • 4.2.2 Advancements in Molecular Diagnostic Techniques
    • 4.2.3 Rising Prevalence of Different Types of Cancer
  • 4.3 Restraints
    • 4.3.1 Stringent Regulatory Policies
  • 4.4 Opportunities
    • 4.4.1 Entering Developing Economies
  • 4.5 Technology Trends & Assessment

5 Market Factor Analysis

  • 5.1 Value Chain Analysis
    • 5.1.1 R&D and Designing
    • 5.1.2 Good Laboratory Practices
    • 5.1.3 Molecular Diagnostics Testing
    • 5.1.4 Distribution and Sales
    • 5.1.5 Post-Sales Monitoring
  • 5.2 Porter's Five Forces Analysis
    • 5.2.1 Bargaining Power of Suppliers
    • 5.2.2 Bargaining Power of Buyers
    • 5.2.3 Threat of New Entrants
    • 5.2.4 Threat of Substitutes
    • 5.2.5 Intensity of Rivalry
  • 5.3 Investment Opportunities
  • 5.4 Pricing Analysis

6 Global Molecular Diagnostics Market, By Product

  • 6.1 Overview
  • 6.2 Reagents & Kits
  • 6.3 Instruments
  • 6.4 Services & Software

7 Global Molecular Diagnostics Market, By Technique

  • 7.1 Overview
  • 7.2 Polymerase Chain Reaction (PCR)
  • 7.3 Isothermal Amplification
  • 7.4 Hybridization
  • 7.5 Sequencing
  • 7.6 Microarray
  • 7.7 Others

8 Global Molecular Diagnostics Market, By Application

  • 8.1 Overview
  • 8.2 Infectious Diseases
  • 8.3 Oncology
  • 8.4 Genetic Tests
  • 8.5 Others

9 Global Molecular Diagnostics Market, By End-User

  • 9.1 Overview
  • 9.2 Hospitals & Clinics
  • 9.3 Diagnostic Laboratories
  • 9.4 Others

10 Global Molecular Diagnostics Market, By Region

  • 10.1 Overview
  • 10.2 Americas
    • 10.2.1 North America
      • 10.2.1.1 US
      • 10.2.1.2 Canada
    • 10.2.2 Latin America
  • 10.3 Europe
    • 10.3.1 Western Europe
      • 10.3.1.1 Germany
      • 10.3.1.2 France
      • 10.3.1.3 UK
      • 10.3.1.4 Italy
      • 10.3.1.5 Spain
      • 10.3.1.6 Rest of Western Europe
    • 10.3.2 Eastern Europe
  • 10.4 Asia-Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 South Korea
    • 10.4.5 Australia
    • 10.4.6 Rest of Asia-Pacific
  • 10.5 Middle East & Africa
    • 10.5.1 Middle East
    • 10.5.2 Africa

11 Competitive Landscape

  • 11.1 Overview
  • 11.2 Company Share Analysis
  • 11.3 Competitive Benchmarking
  • 11.4 Leading Player in Terms of Number of Developments in the Molecular Diagnostics Market
  • 11.5 Key Development Analysis
    • 11.5.1 Partnership/Strategic Agreement
    • 11.5.2 Acquisition
    • 11.5.3 Product Approval
    • 11.5.4 Product Launch

12 Company Profiles

  • 12.1 F. Hoffmann-La Roche Ltd
    • 12.1.1 Company Overview
    • 12.1.2 Financial Overview
    • 12.1.3 Products/Services Offered
    • 12.1.4 Key Developments
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Strategies
  • 12.2 Hologic, Inc.
    • 12.2.1 Company Overview
    • 12.2.2 Financial Overview
    • 12.2.3 Products/Services Offered
    • 12.2.4 Key Developments
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Strategies
  • 12.3 Qiagen
    • 12.3.1 Company Overview
    • 12.3.2 Financial Overview
    • 12.3.3 Products/Services Offered
    • 12.3.4 Key Developments
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Strategies
  • 12.4 Becton, Dickinson, and Company
    • 12.4.1 Company Overview
    • 12.4.2 Financial Overview
    • 12.4.3 Products/Services Offered
    • 12.4.4 Key Developments
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Strategies
  • 12.5 Abbott Laboratories
    • 12.5.1 Company Overview
    • 12.5.2 Financial Overview
    • 12.5.3 Products/Services Offered
    • 12.5.4 Key Developments
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Strategies
  • 12.6 Cepheid
    • 12.6.1 Company Overview
    • 12.6.2 Financial Overview
    • 12.6.3 Products/Services Offered
    • 12.6.4 Key Developments
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Strategies
  • 12.7 Siemens
    • 12.7.1 Company Overview
    • 12.7.2 Financial Overview
    • 12.7.3 Products/Services Offered
    • 12.7.4 Key Developments
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Strategies
  • 12.8 CLONIT srl
    • 12.8.1 Company Overview
    • 12.8.2 Financial Overview
    • 12.8.3 Products/Services Offered
    • 12.8.4 Key Developments
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Strategies
  • 12.9 Thermo Fisher Scientific Inc.
    • 12.9.1 Company Overview
    • 12.9.2 Financial Overview
    • 12.9.3 Products Offering
    • 12.9.4 Key Developments
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Strategies
  • 12.1 Agilent Technologies
    • 12.10.1 Company Overview
    • 12.10.2 Financial Overview
    • 12.10.3 Products/Services Offered
    • 12.10.4 Key Developments
    • 12.10.5 SWOT Analysis
    • 12.10.6 Key Strategies
  • 12.11 EKF Diagnostics
    • 12.11.1 Company Overview
    • 12.11.2 Financial Overview
    • 12.11.3 Products/Services Offered
    • 12.11.4 Key Developments
    • 12.11.5 SWOT Analysis
    • 12.11.6 Key Strategies
  • 12.12 Novartis
    • 12.12.1 Company Overview
    • 12.12.2 Financial Overview
    • 12.12.3 Products/Services Offered
    • 12.12.4 Key Developments
    • 12.12.5 SWOT Analysis
    • 12.12.6 Key Strategies
  • 12.13 Illumina
    • 12.13.1 Company Overview
    • 12.13.2 Financial Overview
    • 12.13.3 Products/Services Offered
    • 12.13.4 Key Developments
    • 12.13.5 SWOT Analysis
    • 12.13.6 Key Strategies

13 Appendix

  • 13.1 References
  • 13.2 Related Reports

List of Tables

  • TABLE 1 MARKET SYNOPSIS
  • TABLE 2 PRIMARY INTERVIEWS
  • TABLE 3 GLOBAL MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2016-2025 (USD MILLION)
  • TABLE 4 GLOBAL MOLECULAR DIAGNOSTICS MARKET, FOR REAGENTS & KITS, BY REGION, 2016-2025 (USD MILLION)
  • TABLE 5 GLOBAL MOLECULAR DIAGNOSTICS MARKET, FOR INSTRUMENTS, BY REGION, 2016-2025 (USD MILLION)
  • TABLE 6 GLOBAL MOLECULAR DIAGNOSTICS MARKET, FOR SERVICES & SOFTWARE, BY REGION, 2016-2025 (USD MILLION)
  • TABLE 7 GLOBAL MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE, 2016-2025 (USD MILLION)
  • TABLE 8 GLOBAL MOLECULAR DIAGNOSTICS MARKET, FOR POLYMERASE CHAIN REACTION (PCR), BY REGION, 2016-2025 (USD MILLION)
  • TABLE 9 GLOBAL MOLECULAR DIAGNOSTICS MARKET, FOR ISOTHERMAL AMPLIFICATION, BY REGION, 2016-2025 (USD MILLION)
  • TABLE 10 GLOBAL MOLECULAR DIAGNOSTICS MARKET, FOR HYBRIDIZATION, BY REGION, 2016-2025 (USD MILLION)
  • TABLE 11 GLOBAL MOLECULAR DIAGNOSTICS MARKET, FOR SEQUENCING, BY REGION, 2016-2025 (USD MILLION)
  • TABLE 12 GLOBAL MOLECULAR DIAGNOSTICS MARKET, FOR MICROARRAY, BY REGION, 2016-2025 (USD MILLION)
  • TABLE 13 GLOBAL MOLECULAR DIAGNOSTICS MARKET, FOR OTHERS, BY REGION, 2016-2025 (USD MILLION)
  • TABLE 14 GLOBAL MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2016-2025 (USD MILLION)
  • TABLE 15 GLOBAL MOLECULAR DIAGNOSTICS MARKET, FOR INFECTIOUS DISEASES, BY REGION, 2016-2025 (USD MILLION)
  • TABLE 16 GLOBAL MOLECULAR DIAGNOSTICS MARKET, FOR ONCOLOGY, BY REGION, 2016-2025 (USD MILLION)
  • TABLE 17 GLOBAL MOLECULAR DIAGNOSTICS MARKET, FOR GENETIC TESTS, BY REGION, 2016-2025 (USD MILLION)
  • TABLE 18 GLOBAL MOLECULAR DIAGNOSTICS MARKET, FOR OTHERS, BY REGION, 2016-2025 (USD MILLION)
  • TABLE 19 GLOBAL MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2016-2025 (USD MILLION)
  • TABLE 20 GLOBAL MOLECULAR DIAGNOSTICS MARKET, FOR HOSPITALS & CLINICS, BY REGION, 2016-2025 (USD MILLION)
  • TABLE 21 GLOBAL MOLECULAR DIAGNOSTICS MARKET, FOR DIAGNOSTIC LABORATORIES, BY REGION, 2016-2025 (USD MILLION)
  • TABLE 22 GLOBAL MOLECULAR DIAGNOSTICS MARKET, FOR OTHERS, BY REGION, 2016-2025 (USD MILLION)
  • TABLE 23 GLOBAL MOLECULAR DIAGNOSTICS MARKET, BY REGION, 2016-2025 (USD MILLION)
  • TABLE 24 AMERICAS: MOLECULAR DIAGNOSTICS MARKET, BY REGION, 2016-2025 (USD MILLION)
  • TABLE 25 AMERICAS: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2016-2025 (USD MILLION)
  • TABLE 26 AMERICAS: MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE, 2016-2025 (USD MILLION)
  • TABLE 27 AMERICAS: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2016-2025 (USD MILLION)
  • TABLE 28 AMERICAS: MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2016-2025 (USD MILLION)
  • TABLE 29 NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET, BY COUNTRY, 2016-2025 (USD MILLION)
  • TABLE 30 NORTH AMERICA: MOLECULAR DIAGNOSTICS, BY COUNTRY, 2018 (%)
  • TABLE 31 NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2016-2025 (USD MILLION)
  • TABLE 32 NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE, 2016-2025 (USD MILLION)
  • TABLE 33 NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2016-2025 (USD MILLION)
  • TABLE 34 NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2016-2025 (USD MILLION)
  • TABLE 35 US: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2016-2025 (USD MILLION)
  • TABLE 36 US: MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE, 2016-2025 (USD MILLION)
  • TABLE 37 US: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2016-2025 (USD MILLION)
  • TABLE 38 US: MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2016-2025 (USD MILLION)
  • TABLE 39 CANADA: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2016-2025 (USD MILLION)
  • TABLE 40 CANADA: MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE, 2016-2025 (USD MILLION)
  • TABLE 41 CANADA: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2016-2025 (USD MILLION)
  • TABLE 42 CANADA: MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2016-2025 (USD MILLION)
  • TABLE 43 LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2016-2025 (USD MILLION)
  • TABLE 44 LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE, 2016-2025 (USD MILLION)
  • TABLE 45 LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2016-2025 (USD MILLION)
  • TABLE 46 LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2016-2025 (USD MILLION)
  • TABLE 47 EUROPE: MOLECULAR DIAGNOSTICS MARKET, BY REGION, 2016-2025 (USD MILLION)
  • TABLE 48 EUROPE: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2016-2025 (USD MILLION)
  • TABLE 49 EUROPE: MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE, 2016-2025 (USD MILLION)
  • TABLE 50 EUROPE: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2016-2025 (USD MILLION)
  • TABLE 51 EUROPE: MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2016-2025 (USD MILLION)
  • TABLE 52 WESTERN EUROPE: MOLECULAR DIAGNOSTICS MARKET, BY COUNTRY, 2016-2025 (USD MILLION)
  • TABLE 53 WESTERN EUROPE: MOLECULAR DIAGNOSTICS, BY COUNTRY, 2018 (%)
  • TABLE 54 WESTERN EUROPE: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2016-2025 (USD MILLION)
  • TABLE 55 WESTERN EUROPE: MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE, 2016-2025 (USD MILLION)
  • TABLE 56 WESTERN EUROPE: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2016-2025 (USD MILLION)
  • TABLE 57 WESTERN EUROPE: MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2016-2025 (USD MILLION)
  • TABLE 58 GERMANY: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2016-2025 (USD MILLION)
  • TABLE 59 GERMANY: MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE, 2016-2025 (USD MILLION)
  • TABLE 60 GERMANY: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2016-2025 (USD MILLION)
  • TABLE 61 GERMANY: MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2016-2025 (USD MILLION)
  • TABLE 62 FRANCE: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2016-2025 (USD MILLION)
  • TABLE 63 FRANCE: MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE, 2016-2025 (USD MILLION)
  • TABLE 64 FRANCE: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2016-2025 (USD MILLION)
  • TABLE 65 FRANCE: MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2016-2025 (USD MILLION)
  • TABLE 66 UK: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2016-2025 (USD MILLION)
  • TABLE 67 UK: MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE, 2016-2025 (USD MILLION)
  • TABLE 68 UK: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2016-2025 (USD MILLION)
  • TABLE 69 UK: MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2016-2025 (USD MILLION)
  • TABLE 70 ITALY: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2016-2025 (USD MILLION)
  • TABLE 71 ITALY: MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE, 2016-2025 (USD MILLION)
  • TABLE 72 ITALY: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2016-2025 (USD MILLION)
  • TABLE 73 ITALY: MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2016-2025 (USD MILLION)
  • TABLE 74 SPAIN: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2016-2025 (USD MILLION)
  • TABLE 75 SPAIN: MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE, 2016-2025 (USD MILLION)
  • TABLE 76 SPAIN: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2016-2025 (USD MILLION)
  • TABLE 77 SPAIN: MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2016-2025 (USD MILLION)
  • TABLE 78 REST OF WESTERN EUROPE: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2016-2025 (USD MILLION)
  • TABLE 79 REST OF WESTERN EUROPE: MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE, 2016-2025 (USD MILLION)
  • TABLE 80 REST OF WESTERN EUROPE: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2016-2025 (USD MILLION)
  • TABLE 81 REST OF WESTERN EUROPE: MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2016-2025 (USD MILLION)
  • TABLE 82 EASTERN EUROPE: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2016-2025 (USD MILLION)
  • TABLE 83 EASTERN EUROPE: MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE, 2016-2025 (USD MILLION)
  • TABLE 84 EASTERN EUROPE: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2016-2025 (USD MILLION)
  • TABLE 85 EASTERN EUROPE: MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2016-2025 (USD MILLION)
  • TABLE 86 ASIA-PACIFIC: MOLECULAR DIAGNOSTICS MARKET, BY COUNTRY, 2016-2025 (USD MILLION)
  • TABLE 87 ASIA-PACIFIC: MOLECULAR DIAGNOSTICS, BY COUNTRY, 2018 (%)
  • TABLE 88 ASIA-PACIFIC: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2016-2025 (USD MILLION)
  • TABLE 89 ASIA-PACIFIC: MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE, 2016-2025 (USD MILLION)
  • TABLE 90 ASIA-PACIFIC: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2016-2025 (USD MILLION)
  • TABLE 91 ASIA-PACIFIC: MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2016-2025 (USD MILLION)
  • TABLE 92 JAPAN: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2016-2025 (USD MILLION)
  • TABLE 93 JAPAN: MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE, 2016-2025 (USD MILLION)
  • TABLE 94 JAPAN: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2016-2025 (USD MILLION)
  • TABLE 95 JAPAN: MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2016-2025 (USD MILLION)
  • TABLE 96 CHINA: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2016-2025 (USD MILLION)
  • TABLE 97 CHINA: MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE, 2016-2025 (USD MILLION)
  • TABLE 98 CHINA: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2016-2025 (USD MILLION)
  • TABLE 99 CHINA: MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2016-2025 (USD MILLION)
  • TABLE 100 INDIA: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2016-2025 (USD MILLION)
  • TABLE 101 INDIA: MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE, 2016-2025 (USD MILLION)
  • TABLE 102 INDIA: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2016-2025 (USD MILLION)
  • TABLE 103 INDIA: MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2016-2025 (USD MILLION)
  • TABLE 104 SOUTH KOREA: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2016-2025 (USD MILLION)
  • TABLE 105 SOUTH KOREA: MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE, 2016-2025 (USD MILLION)
  • TABLE 106 SOUTH KOREA: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2016-2025 (USD MILLION)
  • TABLE 107 SOUTH KOREA: MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2016-2025 (USD MILLION)
  • TABLE 108 AUSTRALIA: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2016-2025 (USD MILLION)
  • TABLE 109 AUSTRALIA: MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE, 2016-2025 (USD MILLION)
  • TABLE 110 AUSTRALIA: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2016-2025 (USD MILLION)
  • TABLE 111 AUSTRALIA: MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2016-2025 (USD MILLION)
  • TABLE 112 REST OF ASIA-PACIFIC: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2016-2025 (USD MILLION)
  • TABLE 113 REST OF ASIA-PACIFIC: MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE, 2016-2025 (USD MILLION)
  • TABLE 114 REST OF ASIA-PACIFIC: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2016-2025 (USD MILLION)
  • TABLE 115 REST OF ASIA-PACIFIC: MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2016-2025 (USD MILLION)
  • TABLE 116 MIDDLE EAST & AFRICA: MOLECULAR DIAGNOSTICS MARKET, BY REGION, 2016-2025 (USD MILLION)
  • TABLE 117 MIDDLE EAST & AFRICA: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2016-2025 (USD MILLION)
  • TABLE 118 MIDDLE EAST & AFRICA: MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE, 2016-2025 (USD MILLION)
  • TABLE 119 MIDDLE EAST & AFRICA: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2016-2025 (USD MILLION)
  • TABLE 120 MIDDLE EAST & AFRICA: MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2016-2025 (USD MILLION)
  • TABLE 121 MIDDLE EAST: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2016-2025 (USD MILLION)
  • TABLE 122 MIDDLE EAST: MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE, 2016-2025 (USD MILLION)
  • TABLE 123 MIDDLE EAST: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2016-2025 (USD MILLION)
  • TABLE 124 MIDDLE EAST: MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2016-2025 (USD MILLION)
  • TABLE 125 AFRICA: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2016-2025 (USD MILLION)
  • TABLE 126 AFRICA: MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE, 2016-2025 (USD MILLION)
  • TABLE 127 AFRICA: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2016-2025 (USD MILLION)
  • TABLE 128 AFRICA: MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2016-2025 (USD MILLION)
  • TABLE 129 TOP PLAYERS IN TERMS OF NUMBER OF DEVELOPMENTS IN THE MOLECULAR DIAGNOSTICS MARKET
  • TABLE 130 PARTNERSHIP/STRATEGIC AGREEMENT
  • TABLE 131 ACQUISITION
  • TABLE 132 MERGER & ACQUISITION
  • TABLE 133 PRODUCT LAUNCH

List of Figures

  • FIGURE 1 GLOBAL MOLECULAR DIAGNOSTICS MARKET: MARKET STRUCTURE
  • FIGURE 2 RESEARCH PROCESS
  • FIGURE 3 TOP-DOWN & BOTTOM-UP APPROACH
  • FIGURE 4 DRIVERS: IMPACT ANALYSIS
  • FIGURE 5 RESTRAINTS: IMPACT ANALYSIS
  • FIGURE 6 VALUE CHAIN: GLOBAL MOLECULAR DIAGNOSTICS MARKET
  • FIGURE 7 PORTER'S FIVE FORCES ANALYSIS: GLOBAL MOLECULAR DIAGNOSTICS MARKET
  • FIGURE 8 GLOBAL MOLECULAR DIAGNOSTICS MARKET SHARE, BY PRODUCT, 2018 (%)
  • FIGURE 9 GLOBAL MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2018 & 2025 (USD MILLION)
  • FIGURE 10 GLOBAL MOLECULAR DIAGNOSTICS MARKET SHARE, BY TECHNIQUE, 2018 (%)
  • FIGURE 11 GLOBAL MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE, 2018 & 2025 (USD MILLION)
  • FIGURE 12 GLOBAL MOLECULAR DIAGNOSTICS MARKET SHARE, BY APPLICATION, 2018 (%)
  • FIGURE 13 GLOBAL MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2018 & 2025 (USD MILLION)
  • FIGURE 14 GLOBAL MOLECULAR DIAGNOSTICS MARKET SHARE, BY END USER, 2018 (%)
  • FIGURE 15 GLOBAL MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2018 & 2025 (USD MILLION)
  • FIGURE 16 GLOBAL MOLECULAR DIAGNOSTICS MARKET SHARE, BY REGION, 2018 (%)
  • FIGURE 17 GLOBAL MOLECULAR DIAGNOSTICS MARKET, BY REGION, 2018 & 2025 (USD MILLION)
  • FIGURE 18 AMERICAS: MOLECULAR DIAGNOSTICS MARKET SHARE, BY REGION, 2018 (%)
  • FIGURE 19 EUROPE: MOLECULAR DIAGNOSTICS MARKET SHARE, BY REGION, 2018 (%)
  • FIGURE 20 MIDDLE EAST & AFRICA: MOLECULAR DIAGNOSTICS MARKET SHARE, BY REGION, 2018 (%)
  • FIGURE 21 GLOBAL MOLECULAR DIAGNOSTICS MARKET SHARE ANALYSIS 2018 (%)
  • FIGURE 22 BENCHMARKING OF MAJOR COMPETITORS
  • FIGURE 23 MOLECULAR DIAGNOSTICS MARKET, COMPETITIVE LANDSCAPE (% SHARE)